KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Teladoc Health (TDOC) over the last 3 years, with Q3 2025 value amounting to $2.6 million.

  • Teladoc Health's Depreciation and Depletion fell 202.55% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 3499.4%. This contributed to the annual value of $10.2 million for FY2024, which is 857.43% down from last year.
  • Teladoc Health's Depreciation and Depletion amounted to $2.6 million in Q3 2025, which was down 202.55% from $4.3 million recorded in Q2 2025.
  • Teladoc Health's 5-year Depreciation and Depletion high stood at $4.3 million for Q2 2025, and its period low was $1.7 million during Q2 2024.
  • For the 3-year period, Teladoc Health's Depreciation and Depletion averaged around $2.9 million, with its median value being $2.8 million (2024).
  • As far as peak fluctuations go, Teladoc Health's Depreciation and Depletion crashed by 4234.94% in 2024, and later skyrocketed by 15472.7% in 2025.
  • Quarter analysis of 3 years shows Teladoc Health's Depreciation and Depletion stood at $2.8 million in 2023, then increased by 6.7% to $3.0 million in 2024, then decreased by 12.35% to $2.6 million in 2025.
  • Its Depreciation and Depletion stands at $2.6 million for Q3 2025, versus $4.3 million for Q2 2025 and $3.6 million for Q1 2025.